Annual short term debt:
$340.25M+$112.63M(+49.48%)Summary
- As of today (September 18, 2025), AMRX annual short term debt is $340.25 million, with the most recent change of +$112.63 million (+49.48%) on December 31, 2024.
- During the last 3 years, AMRX annual short term debt has risen by +$294.22 million (+639.09%).
- AMRX annual short term debt is now at all-time high.
Performance
AMRX Short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly short term debt:
$335.41M-$2.14M(-0.63%)Summary
- As of today (September 18, 2025), AMRX quarterly short term debt is $335.41 million, with the most recent change of -$2.14 million (-0.63%) on June 30, 2025.
- Over the past year, AMRX quarterly short term debt has dropped by -$116.24 million (-25.74%).
- AMRX quarterly short term debt is now -25.74% below its all-time high of $451.65 million, reached on June 30, 2024.
Performance
AMRX quarterly short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Short term debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
AMRX Short term debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +49.5% | -25.7% |
| 3 y3 years | +639.1% | +155.8% |
| 5 y5 years | +820.8% | +612.5% |
AMRX Short term debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +639.1% | -25.7% | +220.5% |
| 5 y | 5-year | at high | +820.8% | -25.7% | +691.9% |
| alltime | all time | at high | >+9999.0% | -25.7% | >+9999.0% |
AMRX Short term debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $335.41M(-0.6%) |
| Mar 2025 | - | $337.54M(-0.8%) |
| Dec 2024 | $340.25M(+49.5%) | $340.25M(-10.7%) |
| Sep 2024 | - | $381.02M(-15.6%) |
| Jun 2024 | - | $451.65M(+97.5%) |
| Mar 2024 | - | $228.66M(+0.5%) |
| Dec 2023 | $227.62M(+117.5%) | $227.62M(+85.8%) |
| Sep 2023 | - | $122.51M(-26.4%) |
| Jun 2023 | - | $166.48M(+14.6%) |
| Mar 2023 | - | $145.22M(+38.8%) |
| Dec 2022 | $104.64M(+127.3%) | $104.64M(-1.8%) |
| Sep 2022 | - | $106.57M(-18.7%) |
| Jun 2022 | - | $131.13M(+182.9%) |
| Mar 2022 | - | $46.35M(+0.7%) |
| Dec 2021 | $46.04M(-20.2%) | $46.04M(+1.3%) |
| Sep 2021 | - | $45.45M(+4.0%) |
| Jun 2021 | - | $43.70M(+3.2%) |
| Mar 2021 | - | $42.36M(-26.6%) |
| Dec 2020 | $57.68M(+56.1%) | $57.68M(+24.9%) |
| Sep 2020 | - | $46.20M(-1.9%) |
| Jun 2020 | - | $47.08M(-86.4%) |
| Mar 2020 | - | $346.94M(+838.9%) |
| Dec 2019 | $36.95M(+70.2%) | $36.95M(-3.5%) |
| Sep 2019 | - | $38.29M(+0.6%) |
| Jun 2019 | - | $38.05M(+0.5%) |
| Mar 2019 | - | $37.85M(+74.3%) |
| Dec 2018 | $21.71M(-75.7%) | $21.71M(-89.1%) |
| Sep 2018 | - | $199.82M(+94.9%) |
| Jun 2018 | - | $102.53M(>+9900.0%) |
| Mar 2018 | - | $0.00(-100.0%) |
| Dec 2017 | $89.48M(+405.0%) | $89.48M(+405.0%) |
| Dec 2016 | $17.72M(>+9900.0%) | - |
| Dec 2016 | - | $17.72M(+0.1%) |
| Sep 2016 | - | $17.71M(>+9900.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(-100.0%) |
| Mar 2015 | - | $18.74M(>+9900.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00 | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | - |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(-100.0%) |
| Jun 2009 | - | $1.89M(-87.0%) |
| Mar 2009 | - | $14.54M(-0.8%) |
| Dec 2008 | $14.66M(-78.8%) | $14.66M(+0.9%) |
| Sep 2008 | - | $14.53M(-77.3%) |
| Jun 2008 | - | $63.98M(-7.6%) |
| Dec 2007 | $69.23M(+3689.5%) | $69.23M(+3689.5%) |
| Dec 2006 | $1.83M(+1545.9%) | $1.83M(-69.1%) |
| Dec 2005 | $111.00K(-98.7%) | - |
| Sep 2004 | - | $5.91M(-0.1%) |
| Jun 2004 | - | $5.92M(-27.1%) |
| Mar 2004 | - | $8.12M(-6.8%) |
| Dec 2003 | $8.71M(+79.2%) | $8.71M(+37.2%) |
| Sep 2003 | - | $6.35M(-7.1%) |
| Jun 2003 | - | $6.83M(-0.7%) |
| Mar 2003 | - | $6.88M(+41.6%) |
| Dec 2002 | $4.86M(+1994.8%) | $4.86M(+1994.8%) |
| Sep 2002 | - | $232.00K(0.0%) |
| Jun 2002 | - | $232.00K(0.0%) |
| Mar 2002 | - | $232.00K(0.0%) |
| Dec 2001 | $232.00K(-91.0%) | $232.00K(+52.6%) |
| Sep 2001 | - | $152.00K(-85.5%) |
| Jun 2001 | - | $1.05M(-37.2%) |
| Mar 2001 | - | $1.67M(-35.1%) |
| Dec 2000 | $2.57M(+10.5%) | $2.57M(-18.9%) |
| Sep 2000 | - | $3.17M(+10.7%) |
| Jun 2000 | - | $2.86M(+14.3%) |
| Mar 2000 | - | $2.50M(+7.6%) |
| Dec 1999 | $2.33M(+140.9%) | $2.33M(+79.0%) |
| Sep 1999 | - | $1.30M(+39.4%) |
| Jun 1999 | - | $932.00K(-34.5%) |
| Mar 1999 | - | $1.42M(+47.4%) |
| Dec 1998 | $965.00K | $965.00K(+11.3%) |
| Sep 1998 | - | $867.00K(+448.7%) |
| Jun 1998 | - | $158.00K(0.0%) |
| Mar 1998 | - | $158.00K |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual short term debt?
- What is the all time high annual short term debt for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual short term debt year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly short term debt?
- What is the all time high quarterly short term debt for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly short term debt year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual short term debt?
The current annual short term debt of AMRX is $340.25M
What is the all time high annual short term debt for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual short term debt is $340.25M
What is Amneal Pharmaceuticals, Inc. annual short term debt year-on-year change?
Over the past year, AMRX annual short term debt has changed by +$112.63M (+49.48%)
What is Amneal Pharmaceuticals, Inc. quarterly short term debt?
The current quarterly short term debt of AMRX is $335.41M
What is the all time high quarterly short term debt for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly short term debt is $451.65M
What is Amneal Pharmaceuticals, Inc. quarterly short term debt year-on-year change?
Over the past year, AMRX quarterly short term debt has changed by -$116.24M (-25.74%)